Growth Hormone Treatment and Left Ventricular Dimensions in Turner Syndrome

Journal of Pediatrics

Volumn 150, Issue 6, 2007, Pages 587-591

  Matura, Lea Ann ^a   Sachdev, Vandana ^b   Bakalov, Vladimir K ^a   Rosing, Douglas R ^b   Bondy, Carolyn A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ADOLESCENT; ADULT; ARTICLE; BODY HEIGHT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART SIZE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT DURATION; TREATMENT OUTCOME; TURNER SYNDROME;

ADOLESCENT; ADULT; BODY SURFACE AREA; CHILD; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; GROWTH HORMONE; HEART; HEART VENTRICLES; HUMAN GROWTH HORMONE; HUMANS; REGRESSION ANALYSIS; TURNER SYNDROME;

EID: 34248524972     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2007.02.009     Document Type: Article

References (25)

1. Nielsen J., and Wohlert M. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet 87 (1991) 81-83
2. Lin A.E., Lippe B.M., Geffner M.E., Gomes A., Lois J.F., Barton C.W., et al. Aortic dilation, dissection, and rupture in patients with Turner syndrome. J Pediatr 109 (1986) 820-826
3. Sybert V.P. Cardiovascular malformations and complications in Turner syndrome. Pediatrics 101 (1998) e11
4. Bondy C. New issues in the diagnosis and management of Turner syndrome. Rev Endocr Metab Disord 6 (2005) 269-280
5. Bondy C.A., Van P.L., Bakalov V.K., Sachdev V., Malone C.A., Ho V.B., et al. Prolongation of the cardiac QTc interval in Turner syndrome. Medicine (Baltimore) 85 (2006) 75-81
6. Bondy C.A., Ceniceros I., Van P.L., Bakalov V.K., and Rosing D.R. Prolonged rate-corrected QT interval and other electrocardiogram abnormalities in girls with Turner syndrome. Pediatrics 118 (2006) e1220-e1225
7. Gravholt C.H., Hansen K.W., Erlandsen M., Ebbehoj E., and Christiansen J.S. Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome. J Hypertens 24 (2006) 353-360
8. Andersen N.H., Hjerrild B.E., Sorensen K., Pedersen E.M., Stochholm K., Gormsen L.C., et al. Subclinical left ventricular dysfunction in normotensive women with Turner's syndrome. Heart 92 (2006) 1516-1517
9. Soriano-Guillen L., Coste J., Ecosse E., Leger J., Tauber M., Cabrol S., et al. Adult height and pubertal growth in Turner syndrome after treatment with recombinant growth hormone. J Clin Endocrinol Metab (2005) -0470
10. Pasquino A.M., Pucarelli I., Segni M., Tarani L., Calcaterra V., and Larizza D. Adult height in sixty girls with Turner syndrome treated with growth hormone matched with an untreated group. J Endocrinol Invest 28 (2005) 350-356
11. The Canadian Growth Hormone Advisory Committee. Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian randomized controlled trial. J Clin Endocrinol Metab 90 (2005) 3360-3366
12. van Pareren Y.K., de Muinck Keizer-Schrama S.M., Stijnen T., Sas T.C., Jansen M., Otten B.J., et al. Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low-dose estrogens. J Clin Endocrinol Metab 88 (2003) 1119-1125
13. Colao A., Vitale G., Pivonello R., Ciccarelli A., Di Somma C., and Lombardi G. The heart: an end-organ of GH action. Eur J Endocrinol 151 (2004) S93-S101
14. Maison P., and Chanson P. Cardiac effects of growth hormone in adults with growth hormone deficiency: a meta-analysis. Circulation 108 (2003) 2648-2652
15. Petersen K.F., Oral E.A., Dufour S., Befroy D., Ariyan C., Yu C., et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109 (2002) 1345-1350
16. Cittadini A., Berggren A., Longobardi S., Ehrnborg C., Napoli R., Rosen T., et al. Supraphysiological doses of GH induce rapid changes in cardiac morphology and function. J Clin Endocrinol Metab 87 (2002) 1654-1659
17. Shulman D.I., Root A.W., Diamond F.B., Bercu B.B., Martinez R., and Boucek Jr. R.J. Effects of one year of recombinant human growth hormone (GH) therapy on cardiac mass and function in children with classical GH deficiency. J Clin Endocrinol Metab 88 (2003) 4095-4099
18. Radetti G., Crepaz R., Paganini C., Gentili L., and Pitscheider W. Medium-term cardiovascular effects of high-dose growth hormone treatment in growth hormone-deficient children. Horm Res 52 (1999) 247-252
19. Radetti G., Crepaz R., Milanesi O., Paganini C., Cesaro A., Rigon F., et al. Cardiac performance in Turner's syndrome patients on growth hormone therapy. Horm Res 55 (2001) 240-244
20. Sas T.C., Cromme-Dijkhuis A.H., de Muinck Keizer-Schrama S.M., Stijnen T., van Teunenbroek A., Drop S.L., and Dutch Working Group on Growth Hormone. The effects of long-term growth hormone treatment on cardiac left ventricular dimensions and blood pressure in girls with Turner's syndrome. J Pediatr 135 (1999) 470-476
21. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., et al., American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2 (1989) 358-367
22. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
23. de Simone G., Daniels S.R., Devereux R.B., Meyer R.A., Roman M.J., de Divitiis O., et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20 (1992) 1251-1260
24. Nathwani N.C., Unwin R., Brook C.G., and Hindmarsh P.C. Blood pressure and Turner syndrome. Clin Endocrinol (Oxf) 52 (2000) 363-370
25. Bondy C.A., Van P.L., Bakalov V.K., and Ho V.B. Growth hormone treatment and aortic dimensions in Turner syndrome. J Clin Endocrinol Metab 91 (2006) 1785-1788